fashion -WSS

fashion

author：hotspot 2025-08-19 15:01:45 - browse：62576

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： India sets sights on home

WSS

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Stanford president to resign after investigation of research

Some dementia cases could be undiagnosed liver disease

FDA drug safety: Singulair case shows systemic surveillance flaws

Seattle police shoot person suspected in downtown stabbing

Medicare drug price negotiation’s day in court

entertainment

fashion

leisure time

Drug repurposing or repositioning? The language matters

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Continuity nursing helped my family in our darkest PICU moments

India sets sights on home

Supreme Court strikes down use of affirmative action

TikTok cracks down on users posting about weight loss drugs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A $475,000 price tag for a new cancer drug: crazy or meh?

Psychedelics group wrestles with new pharma identity

Why the Crimean Bridge is key to Russia's war in Ukraine

explore

Woodcock on FDA’s accelerated approval and her next chapter

Even great ERs can’t make up for American health disparities

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

New warning issued for rebooking air travel after delays, cancellations

Biden administration opens offers in Medicare drug price negotiations

explore

hotspot

explore

Wikipedia